Showing results (21-30 of 80) with videos related to
Sort By:
Pageof 8
Proceedings of the National Academy of Sciences of the United States of America|May 15, 2009
Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the T(H)17 lineage-specific transcription factor RORgamma tMaha Ayyoub, Florence Deknuydt, Isabelle Raimbaud, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2010
Assessment of vaccine-induced CD4 T cell responses to the 119-143 immunodominant region of the tumor-specific antigen NY-ESO-1 using DRB1*0101 tetramersMaha Ayyoub, Pascale Pignon, Danijel Dojcinovic, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2006
Rapamycin-mediated enrichment of T cells with regulatory activity in stimulated CD4+ T cell cultures is not due to the selective expansion of naturally occurring regulatory T cells but to the induction of regulatory functions in conventional CD4+ T cellsDanila Valmori, Valeria Tosello, Naira E Souleimanian, et al.Clinical Immunology (Orlando, Fla.)|July 5, 2005
Identification of B cell epitopes recognized by antibodies specific for the tumor antigen NY-ESO-1 in cancer patients with spontaneous immune responsesDanila Valmori, Naira E Souleimanian, Charles S Hesdorffer, et al.Cancer Research|September 23, 2003
Tumor-reactive, SSX-2-specific CD8+ T cells are selectively expanded during immune responses to antigen-expressing tumors in melanoma patientsMaha Ayyoub, Donata Rimoldi, Philippe Guillaume, et al.Cancer Research|July 17, 2012
CXCR3+ T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunityNassima Redjimi, Caroline Raffin, Isabelle Raimbaud, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2009
Vaccination with a recombinant protein encoding the tumor-specific antigen NY-ESO-1 elicits an A2/157-165-specific CTL repertoire structurally distinct and of reduced tumor reactivity than that elicited by spontaneous immune responses to NY-ESO-1-expressing TumorsGilles Bioley, Philippe Guillaume, Immanuel Luescher, et al.Cancer Science|November 10, 2007
Cross-presentation of NY-ESO-1 cytotoxic T lymphocyte epitope fused to human heat shock cognate protein 70 by dendritic cellsSeiya Susumu, Yasuhiro Nagata, Shinichiro Ito, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2004
Final antigenic Melan-A peptides produced directly by the proteasomes are preferentially selected for presentation by HLA-A*0201 in melanoma cellsLaurence Chapatte, Catherine Servis, Danila Valmori, et al.Cancer Immunology Research|May 29, 2014
Assessment of MAGE-A expression in resected non-small cell lung cancer in relation to clinicopathologic features and mutational status of EGFR and KRASMaha Ayyoub, Lorenzo Memeo, Emilio Alvarez-Fernández, et al.Pageof 8